[HTML][HTML] Nebulized recombinant tissue plasminogen activator (rt-PA) for acute COVID-19-induced respiratory failure: an exploratory proof-of-concept trial
…, R Dimber, C Diaz-Garcia, H Patel, A Nandani… - Journal of Clinical …, 2023 - mdpi.com
… We would like to thank Aarti Nandani and all the staff in the Royal Free clinical trials pharmacy
for their immense support throughout the whole pandemic, especially considering their …
for their immense support throughout the whole pandemic, especially considering their …
[HTML][HTML] Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19
EQ Wey, C Bristow, A Nandani, B O'Farrell… - The Journal of …, 2021 - ncbi.nlm.nih.gov
In this journal, Walsh and colleagues1 recently reviewed the evidence supporting that
immunocompromised patients may remain positive for Severe Acute Respiratory Syndrome …
immunocompromised patients may remain positive for Severe Acute Respiratory Syndrome …
Nebulized recombinant tissue plasminogen activator (rt-PA) for acute COVID-19-induced severe respiratory failure: an exploratory proof of concept trial
…, R Dimber, C Diaz-Garcia, H Patel, A Nandani… - 2023 - preprints.org
… We would like to thank Aarti Nandani and all the staff in the Royal Free clinical trials pharmacy
for their immense support throughout the whole pandemic, especially considering their …
for their immense support throughout the whole pandemic, especially considering their …
Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19 (preprint)
EQ Wey, C Bristow, A Nandani, B O'Farrell, J Pang… - 2021 - pesquisa.bvsalud.org
C-reactive protein (CRP) levels are elevated following bacterial infections but may be
attenuated by the IL-6-receptor antagonist tocilizumab. In hospitalised COVID-19 patients, …
attenuated by the IL-6-receptor antagonist tocilizumab. In hospitalised COVID-19 patients, …
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a …
S Toback, E Galiza, C Cosgrove, J Galloway… - The Lancet …, 2022 - thelancet.com
Background The safety and immunogenicity profile of COVID-19 vaccines when administered
concomitantly with seasonal influenza vaccines have not yet been reported. We therefore …
concomitantly with seasonal influenza vaccines have not yet been reported. We therefore …
Vitamin C for Patients Hospitalized With COVID-19
C McKenzie, L Moore, M Borthwick - JAMA, 2024 - jamanetwork.com
To the Editor The recently published REMAP-CAP and LOVITCOVID studies1 tested the
hypothesis that the administration of high-dose vitamin C (ascorbic acid) increases the number …
hypothesis that the administration of high-dose vitamin C (ascorbic acid) increases the number …
Effects of spironolactone and chlorthalidone on cardiovascular structure and function in chronic kidney disease: a randomized, open-label trial
NC Edwards, AM Price, S Mehta… - Clinical Journal of the …, 2021 - journals.lww.com
Results There was no significant difference in left ventricular mass regression; at week 40,
the adjusted mean difference for spironolactone compared with chlorthalidone was− 3.8 g (95…
the adjusted mean difference for spironolactone compared with chlorthalidone was− 3.8 g (95…
[HTML][HTML] E-Poster Presentation
SV Nandani, J Thakkar - 2019 - journals.lww.com
Background: Mycosis fungoides is a distinct clinico-pathological type of cutaneous T-cell
Lymphoma and represent 50% of all primary cutaneous lymphomas. Traditionally, MF is …
Lymphoma and represent 50% of all primary cutaneous lymphomas. Traditionally, MF is …
[HTML][HTML] The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight
O Bird, EP Galiza, DN Baxter, M Boffito… - Epidemiology and …, 2024 - ncbi.nlm.nih.gov
To investigate the symptoms of SARS-CoV-2 infection, their dynamics and their discriminatory
power for the disease using longitudinally, prospectively collected information reported at …
power for the disease using longitudinally, prospectively collected information reported at …
The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight
O Bird, EP Galiza, DN Baxter, M Boffito… - Epidemiology & …, 2024 - cambridge.org
To investigate the symptoms of SARS-CoV-2 infection, their dynamics and their discriminatory
power for the disease using longitudinally, prospectively collected information reported at …
power for the disease using longitudinally, prospectively collected information reported at …